The Event: Institutional Funding on Great Terms
Post# of 1086
Posted On: 03/05/2014 9:44:32 AM
The Event: Institutional Funding on Great Terms
Two weeks ago, Nuvilex issued the most important release in company history. Noted institutional investor Lincoln Park invested $2M in NVLX stock and based on the agreement, has committed to invest up to an additional $25M in NVLX stock, at the sole option of the Company. The initial tranche was priced at $0.25, a premium to the previous day’s close. We note that this deal included no warrants or options.
Two weeks ago, Nuvilex issued the most important release in company history. Noted institutional investor Lincoln Park invested $2M in NVLX stock and based on the agreement, has committed to invest up to an additional $25M in NVLX stock, at the sole option of the Company. The initial tranche was priced at $0.25, a premium to the previous day’s close. We note that this deal included no warrants or options.
(0)
(0)PharmaCyte Biotech Inc. (PMCB) Stock Research Links
Scroll down for more posts ▼